Novabay Pharmaceuticals (NBY)

Mar 7, 2025, 6:50 AM EST - 6 weeks ago

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

Jan 23, 2025, 8:00 AM EST - 3 months ago

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

Dec 19, 2024, 6:50 AM EST - 4 months ago

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

Dec 9, 2024, 6:50 AM EST - 4 months ago

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

Nov 22, 2024, 4:05 PM EST - 5 months ago

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

Nov 15, 2024, 8:00 AM EST - 5 months ago

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand

Nov 7, 2024, 4:05 PM EST - 5 months ago

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:05 PM EST - 5 months ago

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

Oct 29, 2024, 8:00 AM EDT - 6 months ago

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

Sep 20, 2024, 8:30 AM EDT - 7 months ago

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals

Sep 20, 2024, 8:00 AM EDT - 7 months ago

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

Aug 13, 2024, 11:29 PM EDT - 8 months ago

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 4:05 PM EDT - 8 months ago

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 6:50 AM EDT - 9 months ago

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

Jul 30, 2024, 6:50 AM EDT - 9 months ago

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

Jul 29, 2024, 4:05 PM EDT - 9 months ago

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

Jul 26, 2024, 8:30 AM EDT - 9 months ago

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering

Jul 16, 2024, 6:50 AM EDT - 9 months ago

NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day

Jul 11, 2024, 6:50 AM EDT - 10 months ago

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

Jul 1, 2024, 6:50 AM EDT - 10 months ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

EYEN

Jun 28, 2024, 6:50 AM EDT - 10 months ago

NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions

Jun 7, 2024, 6:50 AM EDT - 11 months ago

NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American

May 29, 2024, 5:22 PM EDT - 11 months ago

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates

May 13, 2024, 8:30 AM EDT - 1 year ago

NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms

May 11, 2024, 1:59 PM EDT - 1 year ago

NovaBay Pharmaceuticals, Inc. (NBY) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results

May 7, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon

May 3, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024

Apr 22, 2024, 6:57 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales

Apr 19, 2024, 6:00 PM EDT - 1 year ago

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

Apr 17, 2024, 6:59 AM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

Mar 26, 2024, 6:43 PM EDT - 1 year ago

NovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results

Mar 25, 2024, 6:38 PM EDT - 1 year ago

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024

Mar 14, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

Jan 30, 2024, 9:00 AM EST - 1 year ago

NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales

Jan 9, 2024, 9:15 AM EST - 1 year ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

SNOA

Dec 6, 2023, 6:50 AM EST - 1 year ago

NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes

Nov 9, 2023, 11:43 PM EST - 1 year ago

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023

Oct 11, 2023, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs

Oct 2, 2023, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference

Sep 14, 2023, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft

Sep 11, 2023, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft

Aug 12, 2023, 2:40 PM EDT - 1 year ago

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Second Quarter 2023 Financial Results

Aug 8, 2023, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals to Hold Second Quarter 2023 Conference Call on August 10, 2023

Jul 14, 2023, 8:30 AM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Record Avenova Sales Day